How Much Does Vaginal Estradiol Cost in New Hampshire in 2026?

New Hampshire Cash Prices for Vaginal Estradiol in 2026

The average cash price for vaginal estradiol across New Hampshire retail pharmacies is $120 per month in 2026. That figure covers all three FDA-approved dosage forms: vaginal cream, vaginal tablet, and the vaginal ring. Brand-name products carry a manufacturer list price of approximately $280 per month, though very few patients pay that full amount.

Prices vary between pharmacy chains and independent pharmacies. A 2024 analysis of Medicare Part D spending data showed that vaginal estradiol cream (Estrace Vaginal Cream and generics) accounted for over 2.4 million prescriptions annually in the United States, making it one of the most commonly dispensed hormone medications for postmenopausal women [1]. That prescription volume helps keep generic competition strong and retail prices below brand-name levels.

New Hampshire has 213 licensed retail pharmacies according to the NH Board of Pharmacy. Prices at large chains like CVS, Walgreens, and Rite Aid tend to cluster within $10 to $15 of each other for generic vaginal estradiol cream. Independent pharmacies may price higher or lower depending on their wholesale agreements. Patients who compare prices using discount platforms often find generic vaginal estradiol cream for $30 to $60 per tube, which lasts four to eight weeks depending on the prescribed dose.

The vaginal ring (Estring), which releases 7.5 mcg of estradiol per 24 hours over 90 days, has a different pricing structure. A single ring typically costs $350 to $500 at cash price, but the per-month cost works out to $117 to $167 because each ring lasts three months [2]. The vaginal tablet (Vagifem/Yuvafem) runs approximately $90 to $180 for a 30-day supply at cash price, depending on the pharmacy.

Why New Hampshire Medicaid Does Not Cover Vaginal Estradiol

New Hampshire Medicaid does not include vaginal estradiol on its preferred drug list for genitourinary syndrome of menopause. This gap affects roughly 180,000 NH Medicaid enrollees.

The coverage exclusion reflects how state Medicaid formularies classify GSM treatments. Federal Medicaid law requires coverage of FDA-approved drugs from manufacturers that participate in the Medicaid Drug Rebate Program, but states retain authority to impose prior authorization requirements and preferred drug lists that can functionally restrict access. New Hampshire's managed care organizations (MCOs), including Granite State Health Plan (now Centene) and NH Healthy Families (also Centene), follow the state's preferred drug list.

Patients on NH Medicaid who need vaginal estradiol for GSM have several options. A prescriber can submit a prior authorization request documenting medical necessity, particularly if the patient has tried and failed non-hormonal alternatives like ospemifene (Osphena) or over-the-counter vaginal moisturizers. The North American Menopause Society (NAMS) 2022 position statement recommends low-dose vaginal estrogen as first-line therapy for GSM symptoms, noting that systemic absorption is minimal and the treatment carries a favorable safety profile even in women with a history of breast cancer [3]. Citing this guideline in a prior authorization letter strengthens the clinical argument.

A second route involves switching to a compounded formulation through a 503A pharmacy, which operates outside the Medicaid formulary system entirely. More on that option below.

Compounded Vaginal Estradiol in New Hampshire: Legal and Available

Compounded vaginal estradiol is legal in New Hampshire through 503A pharmacies. These pharmacies prepare patient-specific formulations under individual prescriptions, and several licensed compounding pharmacies operate within the state.

New Hampshire follows federal guidance under the Drug Quality and Security Act (DQSA) of 2013, which distinguishes between 503A compounding pharmacies (patient-specific, state-regulated) and 503B outsourcing facilities (batch production, FDA-regulated). Both pathways are active in New Hampshire. The NH Board of Pharmacy licenses and inspects 503A compounding pharmacies under RSA 318, the state pharmacy practice act [4].

Compounded vaginal estradiol formulations typically include estriol/estradiol combinations (often called "Biest" creams), estradiol-only creams in custom concentrations, and vaginal suppositories. Pricing varies by pharmacy, but compounded formulations frequently cost less than brand-name commercial products. Some NH compounding pharmacies price estradiol vaginal cream at $40 to $80 for a one- to two-month supply, depending on the concentration and base used.

One important clinical distinction: compounded hormones are not FDA-approved products. The Endocrine Society's 2020 scientific statement on compounded bioidentical hormones noted that compounded products lack the standardized testing for potency, purity, and bioavailability that FDA-approved products undergo [5]. The American College of Obstetricians and Gynecologists (ACOG) recommends FDA-approved vaginal estrogen products as first-line therapy but acknowledges that compounded formulations may be appropriate when a patient needs a dose or delivery form not commercially available [6].

For patients in New Hampshire choosing compounded vaginal estradiol, selecting an accredited pharmacy (PCAB accreditation through the Accreditation Commission for Health Care) adds a layer of quality assurance beyond the minimum state requirements.

Insurance Coverage for Vaginal Estradiol in New Hampshire

Most commercial insurance plans in New Hampshire cover at least one form of vaginal estradiol, though the specific product on formulary varies by plan. Generic vaginal estradiol cream is the most commonly covered formulation.

New Hampshire's individual and small-group market is dominated by Anthem (Elevance Health), Ambetter (Centene), Harvard Pilgrim Health Care, and Cigna. Each insurer maintains its own formulary. Generic vaginal estradiol cream typically falls on Tier 2 (preferred generic) or Tier 3 (non-preferred generic), with copays ranging from $10 to $45 per fill. The vaginal ring (Estring) and brand-name tablets often sit on Tier 3 or require prior authorization.

Employer-sponsored plans in New Hampshire follow similar patterns. A 2023 Kaiser Family Foundation survey found that 83% of covered workers had prescription drug benefits with a tiered formulary, and generic hormone therapies were covered under most plans [7]. Patients on high-deductible health plans (HDHPs) paired with health savings accounts (HSAs) pay full cash price until meeting their deductible, making the discount strategies below especially relevant.

New Hampshire does not have a state-level mandate requiring insurers to cover menopausal hormone therapy. Some states (Oregon, Illinois, New York) have passed or introduced legislation requiring coverage of menopause-related treatments, but New Hampshire has not followed suit as of May 2026.

For patients with Medicare Part D in New Hampshire, vaginal estradiol cream is generally covered. The 2025 Inflation Reduction Act provisions that capped Part D out-of-pocket spending at $2,000 per year apply, which benefits patients taking multiple medications alongside vaginal estradiol.

Discount Programs and Savings Strategies

Several discount pathways can reduce vaginal estradiol costs for New Hampshire patients below the $120 average cash price. The most effective strategy depends on whether the patient has insurance.

Manufacturer copay cards. Allergan (now AbbVie) has offered copay assistance for Estrace Vaginal Cream, and Novo Nordisk offers savings programs for Vagifem. These cards typically reduce insured copays to $25 to $35 per fill. Eligibility requirements exclude patients on government insurance (Medicare, Medicaid, Tricare). Patients must check current program status directly with the manufacturer, as terms change annually.

Pharmacy discount platforms. GoodRx, RxSaver, and SingleCare negotiate discounted rates with pharmacies independent of insurance. In New Hampshire, GoodRx coupons have brought generic vaginal estradiol cream prices to $28 to $55 per tube at major chains. These platforms are free to use and work at the point of sale.

Mail-order pharmacies. Mark Cuban's Cost Plus Drugs and Amazon Pharmacy both carry generic vaginal estradiol cream. Cost Plus Drugs uses a transparent pricing model (manufacturer cost + 15% margin + $5 dispensing fee), which has priced generic estradiol cream at $8 to $20 per tube in some formulations.

Patient assistance programs. AbbVie's patient assistance program covers Estrace Vaginal Cream for uninsured patients earning below 400% of the federal poverty level ($62,400 for a single individual in 2026). Application requires proof of income and a prescriber signature.

340B pharmacies. New Hampshire has several federally qualified health centers (FQHCs) and 340B-eligible entities that purchase medications at steep discounts and may pass savings to qualifying patients. Lamprey Health Care, Ammonoosuc Community Health Services, and Mid-State Health Center all participate in the 340B program.

Clinical Context: Why Vaginal Estradiol Matters

Genitourinary syndrome of menopause affects up to 84% of postmenopausal women, according to a 2019 prevalence study published in Menopause [8]. Symptoms include vaginal dryness, burning, irritation, dyspareunia (painful intercourse), and recurrent urinary tract infections. GSM is progressive. It does not resolve without treatment.

Low-dose vaginal estradiol is the most extensively studied treatment for GSM. A 2016 Cochrane systematic review of 30 randomized controlled trials (N=6,235) found that all forms of local vaginal estrogen (cream, ring, and tablet) were equally effective at relieving GSM symptoms, with no significant differences in efficacy between formulations [9]. The review also confirmed that systemic estradiol absorption from low-dose vaginal products remains well below the postmenopausal range, with serum estradiol levels staying under 20 pg/mL in most studies.

The FDA approved vaginal estradiol cream (Estrace) in 1993. It approved the vaginal ring (Estring) in 1996. The vaginal tablet (Vagifem) received approval in 1998, with a lower-dose 10 mcg version (Yuvafem) approved in 2014 [10]. All formulations use 17-beta estradiol, which is bioidentical to the estradiol produced by human ovaries.

Standard dosing for vaginal estradiol cream is 2 to 4 grams applied intravaginally daily for two weeks, then reduced to a maintenance dose of 1 to 2 grams twice weekly. The vaginal tablet uses a 10 mcg dose inserted daily for two weeks, then twice weekly. The ring is inserted once and remains in place for 90 days before replacement.

"Low-dose vaginal estrogen therapy is recommended as the most effective treatment for GSM when the predominant concern is vaginal symptoms," states the 2022 NAMS position statement on hormone therapy [3]. Dr. Stephanie Faubion, NAMS medical director, has noted that "GSM remains dramatically undertreated, with fewer than 7% of affected women receiving prescription therapy."

Telehealth Access in New Hampshire

Telehealth prescribing of vaginal estradiol is legal in New Hampshire. The state's telehealth parity law (RSA 415-J) requires commercial insurers to cover telehealth visits at the same rate as in-person visits, and prescribers can issue prescriptions for vaginal estradiol after a video or audio consultation.

New Hampshire followed other states in making pandemic-era telehealth flexibilities permanent. Governor Sununu signed HB 1622 in 2022, which codified audio-only telehealth visits and maintained prescribing authority for clinicians using telehealth platforms. This means a patient in rural Coos County has the same access to a menopause specialist as someone in Manchester or Nashua.

Several national telehealth platforms prescribe vaginal estradiol to New Hampshire residents, including Midi Health (menopause-focused), Evernow, and Alloy. HealthRX also provides telehealth hormone therapy consultations for New Hampshire patients. These platforms typically charge a consultation fee ($75 to $199 for an initial visit) and then send prescriptions to the patient's preferred pharmacy.

For patients considering telehealth, the key advantage is access to clinicians who specialize in menopause medicine. A 2020 survey published in Menopause found that only 6.8% of OB-GYN residency programs provided any formal menopause medicine training [11]. Telehealth platforms staffed by NAMS-certified menopause practitioners may offer more specialized care than a local primary care visit, particularly for complex cases involving breast cancer history or concurrent hormone therapy.

Comparing Formulations by Cost and Convenience

Each vaginal estradiol formulation carries different cost and practical trade-offs for New Hampshire patients.

Vaginal cream (generic estradiol cream, 0.01%) offers the lowest cash price and greatest dose flexibility. Prescribers can titrate the amount applied per dose. The drawback: cream is messy. Many patients find the applicator-based delivery inconvenient, and some experience vaginal discharge after application. A tube of generic estradiol cream (42.5 g) typically lasts four to eight weeks.

Vaginal tablet (Yuvafem, generic vaginal estradiol tablet 10 mcg) provides cleaner, more consistent dosing. The small tablet is inserted with a disposable applicator. Generic versions became available in 2018, bringing costs down substantially. Cash price runs $90 to $180 for an 18-count supply (about 4.5 weeks at maintenance dosing).

Vaginal ring (Estring, 2 mg releasing 7.5 mcg/24 hours) requires the least ongoing effort. Insert once, leave for 90 days. No applicators, no twice-weekly dosing to remember. The per-month cost ($117 to $167 at cash price) is competitive with cream, but the upfront cost of $350 to $500 per ring creates a higher single-fill expense. Estring does not yet have a generic equivalent.

The 2016 Cochrane review found no efficacy differences between these three formulations for treating GSM symptoms [9]. Patient preference, cost, and insurance formulary placement should guide the choice.

Steps to Get Vaginal Estradiol in New Hampshire at the Lowest Cost

A practical sequence for minimizing out-of-pocket spending:

1. Check insurance formulary first. Call the number on the back of the insurance card and ask which vaginal estradiol product is on the preferred tier. Start there.

2. Run discount card comparisons. Even with insurance, compare the insured copay against GoodRx or SingleCare pricing. Sometimes the discount card price beats the insurance copay, especially early in the plan year before the deductible is met.

3. Ask about 90-day fills. Many insurers and discount platforms offer lower per-unit pricing on 90-day supplies. For maintenance therapy, this can reduce the per-month cost by 15% to 30%.

4. Consider mail-order. Cost Plus Drugs and Amazon Pharmacy price transparently and ship to New Hampshire addresses. Compare their prices against local retail.

5. Evaluate compounded options. If cost remains a barrier, ask the prescriber about a compounded vaginal estradiol formulation from a licensed NH 503A pharmacy.

6. Apply for patient assistance. Uninsured patients earning below 400% FPL should apply to the manufacturer's patient assistance program before paying cash.

Vaginal estradiol at maintenance dosing (twice weekly) provides effective, long-term relief from GSM symptoms. The 10 mcg vaginal tablet delivers approximately 3.5 mcg of systemic estradiol absorption per day, well below the threshold associated with endometrial stimulation, according to pharmacokinetic data from the FDA approval studies [10].